Loading...
Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease
Background: Reduction of serum LDL-cholesterol by statins was shown to improve clinical outcomes in patients with coronary heart disease (CHD). Although intensive statin therapy significantly reduced cardiovascular risks, atherosclerotic cardiovascular events have not been completely prevented. Ther...
Na minha lista:
| Udgivet i: | J Atheroscler Thromb |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Japan Atherosclerosis Society
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7399286/ https://ncbi.nlm.nih.gov/pubmed/26803913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.32813 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|